Biomolecular Surfaces for the Capture and Reprogramming of Circulating Tumor Cells

[1]  G S Kansas,et al.  Selectins and their ligands: current concepts and controversies. , 1996, Blood.

[2]  M. Edelman,et al.  The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. , 1996, Urology.

[3]  C. Pona,et al.  Effectiveness of Leukocyte Filters in Reducing Tumor Cell Contamination after Intraoperative Blood Salvage in Lung Cancer Patients , 1997, Vox sanguinis.

[4]  G. Nash,et al.  Effects of fluorescent dyes on selectin and integrin-mediated stages of adhesion and migration of flowing leukocytes. , 2000, Journal of immunological methods.

[5]  H. Kalthoff,et al.  Disseminated tumour cells , 2001, Virchows Archiv.

[6]  K. Oldhafer,et al.  Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter , 2001, Perfusion.

[7]  M. Fornaro,et al.  Fibronectin Protects Prostate Cancer Cells from Tumor Necrosis Factor-α-induced Apoptosis via the AKT/Survivin Pathway* , 2003, Journal of Biological Chemistry.

[8]  T. Wobbes,et al.  Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  P. Gassmann,et al.  Role of Tumor Cell Adhesion and Migration in Organ-Specific Metastasis Formation , 2004, Oncology Research and Treatment.

[10]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[11]  W. J. Allard,et al.  Circulating tumor cells predict survival in patients with metastatic prostate cancer. , 2005, Urology.

[12]  C Hollmann,et al.  DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD , 2005, Critical reviews in clinical laboratory sciences.

[13]  S. Barthel,et al.  Targeting selectins and selectin ligands in inflammation and cancer , 2007, Expert opinion on therapeutic targets.

[14]  A. Cuello,et al.  Preparation and characterization of new anti-PSMA monoclonal antibodies with potential clinical use. , 2007, Hybridoma.

[15]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[16]  M. L. Blair,et al.  Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device , 2008, British journal of haematology.

[17]  J. Liesveld,et al.  P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. , 2008, Clinical chemistry.

[18]  J. Liesveld,et al.  Delivery of apoptotic signal to rolling cancer cells: A novel biomimetic technique using immobilized TRAIL and E‐selectin , 2009, Biotechnology and bioengineering.